Seladelpar

Lyvdelzi

10 MG CapsuleCanadaMarketedAuthorised 25 Nov 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Lyvdelzi 10 MG Capsulas DurasSpain · 14,104 mg · cápsula dura · Gilead Sciences Ireland Unlimited CompanySame brand
Lyvdelzi (previously Seladelpar Gilead)European Union · Gilead Sciences Ireland Unlimited CompanySame brand
LyvdelziCroatiaSame brand
LyvdelziItaly · Capsula rigida · Gilead Sciences Ireland UcSame brand
Lyvdelzi 10 mg harde capsulesNetherlands · Capsule, hard · Gilead Sciences Ireland UCSame brand
LivdelziUnited States · 10MG BASE · capsule · Gilead Sciences INCSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Seladelpar

Lyvdelzi

10 MG CapsuleCanadaMarketedAuthorised 25 Nov 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Seladelpar
Strength: 10 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 25 Nov 2025
Registration: DIN 02561492
Marketing authorisation holder: Gilead Sciences Canada INC
ATC code: A05AX07
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION